431 related articles for article (PubMed ID: 25071331)
1. Cachexia and pancreatic cancer: are there treatment options?
Mueller TC; Burmeister MA; Bachmann J; Martignoni ME
World J Gastroenterol; 2014 Jul; 20(28):9361-73. PubMed ID: 25071331
[TBL] [Abstract][Full Text] [Related]
2. Nutritional and immune impairments and their effects on outcomes in early pancreatic cancer patients undergoing pancreatoduodenectomy.
Tumas J; Tumiene B; Jurkeviciene J; Jasiunas E; Sileikis A
Clin Nutr; 2020 Nov; 39(11):3385-3394. PubMed ID: 32184025
[TBL] [Abstract][Full Text] [Related]
3. Predictors of Pancreatic Cancer-Associated Weight Loss and Nutritional Interventions.
Nemer L; Krishna SG; Shah ZK; Conwell DL; Cruz-Monserrate Z; Dillhoff M; Guttridge DC; Hinton A; Manilchuk A; Pawlik TM; Schmidt CR; Talbert EE; Bekaii-Saab T; Hart PA
Pancreas; 2017 Oct; 46(9):1152-1157. PubMed ID: 28902785
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic cancer: Best supportive care.
Védie AL; Neuzillet C
Presse Med; 2019 Mar; 48(3 Pt 2):e175-e185. PubMed ID: 30878334
[TBL] [Abstract][Full Text] [Related]
5. Cachexia in pancreatic cancer: new treatment options and measures of success.
Fearon KC; Baracos VE
HPB (Oxford); 2010 Jun; 12(5):323-4. PubMed ID: 20590907
[No Abstract] [Full Text] [Related]
6. Cachexia worsens prognosis in patients with resectable pancreatic cancer.
Bachmann J; Heiligensetzer M; Krakowski-Roosen H; Büchler MW; Friess H; Martignoni ME
J Gastrointest Surg; 2008 Jul; 12(7):1193-201. PubMed ID: 18347879
[TBL] [Abstract][Full Text] [Related]
7. Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: a systematic review.
Ozola Zalite I; Zykus R; Francisco Gonzalez M; Saygili F; Pukitis A; Gaujoux S; Charnley RM; Lyadov V
Pancreatology; 2015; 15(1):19-24. PubMed ID: 25524484
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic cancer related cachexia: influence on metabolism and correlation to weight loss and pulmonary function.
Bachmann J; Ketterer K; Marsch C; Fechtner K; Krakowski-Roosen H; Büchler MW; Friess H; Martignoni ME
BMC Cancer; 2009 Jul; 9():255. PubMed ID: 19635171
[TBL] [Abstract][Full Text] [Related]
9. Three cachexia phenotypes and the impact of fat-only loss on survival in FOLFIRINOX therapy for pancreatic cancer.
Kays JK; Shahda S; Stanley M; Bell TM; O'Neill BH; Kohli MD; Couch ME; Koniaris LG; Zimmers TA
J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):673-684. PubMed ID: 29978562
[TBL] [Abstract][Full Text] [Related]
10. A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer.
Solheim TS; Laird BJA; Balstad TR; Stene GB; Bye A; Johns N; Pettersen CH; Fallon M; Fayers P; Fearon K; Kaasa S
J Cachexia Sarcopenia Muscle; 2017 Oct; 8(5):778-788. PubMed ID: 28614627
[TBL] [Abstract][Full Text] [Related]
11. Update on anorexia and cachexia.
Strasser F; Bruera ED
Hematol Oncol Clin North Am; 2002 Jun; 16(3):589-617. PubMed ID: 12170570
[TBL] [Abstract][Full Text] [Related]
12. Incidence and frequency of cancer cachexia during chemotherapy for advanced pancreatic ductal adenocarcinoma.
Mitsunaga S; Kasamatsu E; Machii K
Support Care Cancer; 2020 Nov; 28(11):5271-5279. PubMed ID: 32103356
[TBL] [Abstract][Full Text] [Related]
13. The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy.
Zhong X; Pons M; Poirier C; Jiang Y; Liu J; Sandusky GE; Shahda S; Nakeeb A; Schmidt CM; House MG; Ceppa EP; Zyromski NJ; Liu Y; Jiang G; Couch ME; Koniaris LG; Zimmers TA
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1083-1101. PubMed ID: 31286691
[TBL] [Abstract][Full Text] [Related]
14. Effect of a leucine-rich supplement in combination with nutrition and physical exercise in advanced cancer patients: A randomized controlled intervention trial.
Storck LJ; Ruehlin M; Gaeumann S; Gisi D; Schmocker M; Meffert PJ; Imoberdorf R; Pless M; Ballmer PE
Clin Nutr; 2020 Dec; 39(12):3637-3644. PubMed ID: 32340904
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of skeletal muscle degradation and its therapy in cancer cachexia.
Melstrom LG; Melstrom KA; Ding XZ; Adrian TE
Histol Histopathol; 2007 Jul; 22(7):805-14. PubMed ID: 17455154
[TBL] [Abstract][Full Text] [Related]
16. Treatment of cachexia: an overview of recent developments.
von Haehling S; Anker SD
J Am Med Dir Assoc; 2014 Dec; 15(12):866-72. PubMed ID: 25455531
[TBL] [Abstract][Full Text] [Related]
17. Osteopenia is associated with wasting in pancreatic adenocarcinoma and predicts survival after surgery.
Cameron ME; Underwood PW; Williams IE; George TJ; Judge SM; Yarrow JF; Trevino JG; Judge AR
Cancer Med; 2022 Jan; 11(1):50-60. PubMed ID: 34791809
[TBL] [Abstract][Full Text] [Related]
18. [Feeding-related disorders in medicine, with special reference to cancer anorexia-cachexia syndrome].
Inui A
Rinsho Byori; 2006 Oct; 54(10):1044-51. PubMed ID: 17133993
[TBL] [Abstract][Full Text] [Related]
19. Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions.
Siddiqui JA; Pothuraju R; Jain M; Batra SK; Nasser MW
Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188359. PubMed ID: 32222610
[TBL] [Abstract][Full Text] [Related]
20. Nutritional counseling and nutritional supplements: a cornerstone of multidisciplinary cancer care for cachectic patients.
Isenring EA; Teleni L
Curr Opin Support Palliat Care; 2013 Dec; 7(4):390-5. PubMed ID: 24189894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
